Loading...
•
Dec 31, 2023
Health Catalyst Q4 2023 Earnings Report
Health Catalyst's financial results for Q4 and year-end 2023 were reported, showing revenue growth and strategic leadership changes.
Key Takeaways
Health Catalyst reported a 9% increase in total revenue for Q4 2023, reaching $75.1 million, and a significant improvement in Adjusted EBITDA to $1.4 million. The company also announced leadership changes, with a new CFO and COO effective March 1, 2024.
Total revenue increased by 9% year-over-year for the quarter ended December 31, 2023, reaching $75.1 million.
Adjusted EBITDA improved significantly to $1.4 million, a 324% increase compared to the same quarter last year.
Leadership changes were announced, including a new CFO and COO, effective March 1, 2024.
Full year 2023 revenue reached $295.9 million, and Adjusted EBITDA was $11.0 million.
Revenue by Segment
Forward Guidance
Health Catalyst provides forward-looking guidance on total revenue and Adjusted EBITDA for the first quarter and full year of 2024.
Positive Outlook
- Total revenue between $72.5 million and $76.5 million for Q1 2024.
- Adjusted EBITDA between $2.0 million and $4.0 million for Q1 2024.
- Total revenue between $304 million and $312 million for the full year 2024.
- Adjusted EBITDA between $24 million and $26 million for the full year 2024.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...